Press release
Hyperphosphatemia Therapeutics Market 2019 - Global Trends, Statistics, Size, Share, Regional Analysis by Key Players | Industry Forecast by Categories, Platform, End – User
The study is titled,” Hyperphosphatemia Therapeutics Market Size, Share and Global Trend By Product (Calcium-based phosphate binders, Aluminium-based phosphate binders, Magnesium-based phosphate binders, Iron-based phosphate binders), Dosage From (Tablets, Syrups, Capsules), Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies) and Geography Forecast till 2026.”
Request Sample Copy at
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/hyperphosphatemia-therapeutics-market-100325
Top Players Overview:
Some of the leading companies that are operating in the Global Hyperphosphatemia Therapeutics
Market are
• Johnson & Johnson Services, Inc.
• Keryx Biopharmaceuticals, Inc.
• Astellas Pharma Inc.
• Ardelyx, BioLink Life Sciences, Inc.
• Lupin Pharmaceuticals, Inc.
• Fresenius Medical Care AG & Co. KGa
• Vifor Pharma Management Ltd.
• other players.
Rising Cases of Chronic Kidney Disorders and Renal Problems Boosting Market
At present, the introduction and utilization of new drugs that are developed for treating chronic diseases is helping the market gain quick momentum. This is because of the adverse effects of such drugs that are boosting the global market for Hyperphosphatemia therapeutics during the forecast duration.
Hyperphosphatemia is caused as a result of excessive phosphate level in the blood. Phosphate being an important component for genetic coding, cell and bone arrangement, and energy metabolism is essential form of phosphorous for the body.
People with kidney disorders and especially end-stage kidney disease commonly face problems such as hyperphosphatemia. Thus, the rising incidences of kidney problems are anticipated to boost the global market for hyperphosphatemia.
Other factors responsible for the rapid expansion of the global hyperphosphatemia market include the rising incidences of diabetic ketoacidosis, high vitamin D levels, low parathyroid hormone levels, and uncontrolled diabetics. The geriatric population is more prone to fall prey to such health disorders, which is further expected to help drive the market during the forecast period.
On the flipside, the lack of awareness about hyperphosphatemia and its benefits may restrict the market from growing in future. Additionally, the high cost of treatment and medication related to the hyperphosphatemia therapeutics may also hinder its growth in future. This, coupled with non-adherence to treatment regimens may also hamper its growth during the forecast period.
Nevertheless, the increasing number of patients undergoing dialysis may bring lucrative growth opportunities for the market in the long run. This is because patients suffering from renal failure or in end stage of kidney disease require phosphorous in their medication.
Speak to Analyst:
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/hyperphosphatemia-therapeutics-market-100325
Asia Pacific to Witness Faster Growth on Account of Better Reimbursement Policies
Fortune Business Insights foresees the global hyperphosphatemia therapeutics market to be dominated by North America. This is owing to the rising incidences of kidney diseases in the region. Additionally, the presence of well-developed health infrastructures is further propelling demand for new and advanced treatment for hyperphosphatemia in the region, thus, boosting market growth.
Furthermore, the market in Asia Pacific is expected to show faster growth in the forecast period, owing to the rising disposable income of people in the region which helps them to opt for better treatment options. Again, reimbursement policies issued by governments in developing nations of China and India are also helping people in the region opt for hyperphosphatemia therapeutics.
Again, the increasing number of healthcare organizations and betterment of facilities in such organizations is also expected to help surge the market in future.
Some of the companies operating in the global Hyperphosphatemia therapeutics market are Fresenius Medical Care AG & Co. KGaA, Astellas Pharma Inc., Vifor Pharma Management Ltd., Keryx Biopharmaceuticals, Inc., Ardelyx, Lupin Pharmaceuticals, Inc., BioLink Life Sciences, Inc., and Johnson & Johnson Services, Inc.
Browse Complete Report Details at
https://www.fortunebusinessinsights.com/industry-reports/hyperphosphatemia-therapeutics-market-100325
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hyperphosphatemia Therapeutics Market 2019 - Global Trends, Statistics, Size, Share, Regional Analysis by Key Players | Industry Forecast by Categories, Platform, End – User here
News-ID: 1853995 • Views: …
More Releases from Fortune Business Insights Pvt Ltd
Commercial Drone Market Size, Share, Industry Development, Growth & Trends by 20 …
The global commercial drone market size was valued at USD 8.77 billion in 2022. The market is projected to grow from USD 10.98 billion in 2023 to USD 54.81 billion by 2030, exhibiting a CAGR of 25.82% during the forecast period. A drone, also known as an unmanned aerial vehicle, is a flying device, equipped with a camera and sensor. Different industries are investing in drone technology and trying to…
Aircraft Engine Market Latest Key Drivers and Future Demand Forecast by 2029
According to a recent report by Fortune Business Insights, the global Aircraft Engine Market is expected to reach a size of USD 112.61 billion by 2028, growing at a CAGR of 10.87% during the forecast period 2021-2028. The report offers a thorough analysis of the market size, regional landscape, revenue forecasts, and upcoming challenges in the market. It also provides current statistics and future predictions, aiming to evaluate growth prospects,…
Space Mining Market the Development Strategies Adopted by Major Key Players And …
The increasing investments by mining companies is expected to foster healthy growth of the market during the forecast period, sates Fortune Business Insights in a report, titled "Space Mining Market Size, Share & Industry Analysis, By Phase (Spacecraft Design, Launch, Operation), By Asteroid type (Type C, Type S, Type M, Others), By Application (Construction, Resource Harvesting, 3D Printing, Others) and Regional Forecast, 2023-2030." The growing number of government initiatives for…
Radar Level Transmitter Market Size, Gross Margin, Trends, Future Demand, Analys …
The higher level of accuracy, reliability, and stability offered by radar level transmitters is expected to fuel the demand of the market during the forecast period, states Fortune Business Insights, in a report, titled "Radar Level Transmitter Market Size, Share & Industry Analysis, By Technology (Contact, Noncontact), By Frequency Range (C and X Band, W Band, K Band), By Application (Liquids, slurries, and interfaces, Solids), By Industry (Oil & Gas,…
More Releases for Hyperphosphatemia
Sustainable Growth Of Hyperphosphatemia Treatment Market Amid Rising Chronic Dis …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Will the Hyperphosphatemia Treatment Industry Market Size Be by 2025?
The market for hyperphosphatemia treatment has expanded quickly in recent years. Its size is set to increase from $4.56 billion in 2024 to $5.13 billion in 2025, with a compound annual growth rate (CAGR) of 12.4%. The extension during the historical period is…
Key Influencer in the Hyperphosphatemia Treatment Market 2025: Sustainable Growt …
What industry-specific factors are fueling the growth of the hyperphosphatemia treatment market?
The rise in chronic illnesses among patients is boosting the hyperphosphatemia treatment market. Conditions like cardiovascular and kidney diseases, chronic respiratory conditions, hyperparathyroidism, diabetes, and cancer all fall under the category of chronic diseases, which are non-communicable and demand long-term management. For instance, the World Health Organization reported in September 2023 that 74% of the 41 million global deaths…
Hyperphosphatemia Pipeline Insight Report 2024
(Albany, United States) As per DelveInsight's assessment, globally, the Hyperphosphatemia Pipeline constitutes 15+ key companies continuously working towards developing 15+ Hyperphosphatemia Pipeline treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight.
In the Hyperphosphatemia Pipeline Report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, Hyperphosphatemia NDA approvals (if any), and product development activities comprising…
Hyperphosphatemia Drugs Market to Witness Robust Expansion by 2029
The Hyperphosphatemia Drugs Market size is expected to grow at an annual average of CAGR 2% during the forecast period (2023-2029). Hyperphosphatemia is characterized by an elevated level of phosphate in the blood as a result of increased intake of phosphate, migration of phosphate out of the cells, and decreased excretion of phosphate. Hyperphosphatemia is frequently found in people who suffer from chronic kidney diseases, diabetic uncontrolled diabetes, and low…
Hyperphosphatemia- Market Insight, Epidemiology and Market Forecast -2030
Hyperphosphatemia Market research report is the new statistical data source added by Infinity Business Insights.
Hyperphosphatemia is a condition in which your blood contains a lot of phosphate (or phosphorus). Phosphate is an electrolyte, a chemically charged compound containing the mineral phosphorus. Phosphate is required by your body to strengthen your bones and teeth, create energy, and construct cell membranes. Phosphate, on the other hand, in excess can cause bone…
Hyperphosphatemia Drugs Market Opportunity Analysis, 2018 - 2026
Hyperphosphatemia is a condition caused due to high level of phosphate or phosphorous in the blood. Phosphate is a chemical found in body and contain mineral called phosphorous. Phosphorus mineral is very important for the development of teeth and bones and also convert food into energy for body. Phosphate is mainly found in the teeth, bones, inside the cells, and in very smaller amounts in the blood. Kidney functions for…
